Compare Novo Nordisk A/S (NVO) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Uranium Energy Corp — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Uranium Energy Corp trades at $9.6 (market cap $4.65B). The key difference: Novo Nordisk A/S is far larger — about 47.4× Uranium Energy Corp's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals.
| NVO | UEC | |
|---|---|---|
Market Cap | $220.53B | $4.65B |
Sector | Health | Energy |
52-Week High | $71.70 | $20.14 |
52-Week Low | $35.29 | $8.00 |
Enterprise Value | $239.49B | $4.16B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
